Ozempic, Wegovy, Zepbound, Mounjaro. Confused? You're Not Alone.
Four names. Two medicines. And a lot of confident opinions from people who aren’t your doctor. Here’s what sets them apart, and how to think about which one, if any, fits you.
Quick Answer: What's the Difference Between Ozempic, Wegovy, Zepbound, and Mounjaro?
Wegovy and Ozempic are both semaglutide. Zepbound and Mounjaro are both tirzepatide. Wegovy and Zepbound are FDA-approved for chronic weight management; Ozempic and Mounjaro are approved for type 2 diabetes, so using them for weight loss is off-label. In head-to-head research, tirzepatide produced more average weight loss than semaglutide. The right one for you depends on your health history, your insurance, and how your body responds.
That’s the whole picture in one paragraph. The rest of this page explains each part of it, so you can walk into a conversation with a physician already knowing the right questions.
Ozempic vs. Wegovy vs. Zepbound vs. Mounjaro: Side by Side
| Comparison | Wegovy | Ozempic | Zepbound | Mounjaro |
|---|---|---|---|---|
| Active ingredient | Semaglutide | Semaglutide | Tirzepatide | Tirzepatide |
| How it works | Acts on GLP-1 receptors | Acts on GLP-1 receptors | Acts on GLP-1 and GIP receptors | Acts on GLP-1 and GIP receptors |
| FDA-approved for | Chronic weight management; lowering the risk of heart attack and stroke in adults with heart disease and overweight or obesity; a type of fatty liver disease (MASH) with liver scarring | Type 2 diabetes, including lowering certain heart and kidney risks in some adults with diabetes | Chronic weight management; moderate to severe obstructive sleep apnea in adults with obesity | Type 2 diabetes |
| How it’s taken | Once-weekly injection; a once-daily pill version is also approved | Once-weekly injection | Once-weekly injection (pen or vial) | Once-weekly injection |
| Used for weight loss | Yes, as approved | Off-label | Yes, as approved | Off-label |
| Insurance usually covers it for | Weight management, if your plan includes it | Type 2 diabetes | Weight management or sleep apnea, if your plan includes it | Type 2 diabetes |
This is a summary, not the full prescribing information. Your physician reviews the complete details with you.
How GLP-1 Medications Work for Weight Loss
After you eat, your gut releases a hormone called GLP-1. It tells your brain you’re full, slows your stomach down, and helps steady your blood sugar. Semaglutide (Wegovy and Ozempic) mimics that hormone. Tirzepatide (Zepbound and Mounjaro) mimics it and a second one, GIP, at the same time.
The effect most patients notice first isn’t on the scale. It’s in their head. The constant background hum about food gets quiet. Portions that used to feel small feel like enough.
That’s the part worth understanding. These medications aren’t willpower in a pen. They work on the biology that makes losing weight, and keeping it off, so hard for so many people. If you’ve lost and regained before, that biology is a big part of why.
How Much Weight Can You Lose on Wegovy or Zepbound?
In the clinical trials that led to approval for weight management, adults taking Wegovy lost about 15% of their body weight on average over 68 weeks. Adults on the highest dose of Zepbound lost about 21% over 72 weeks. Both trials paired the medication with diet and activity changes.
In a head-to-head trial published in 2025, people taking tirzepatide lost more weight on average than people taking semaglutide. Ozempic and Mounjaro were studied mainly in people with type 2 diabetes, where weight loss was measured but wasn’t the main goal.
Averages aren’t promises. Two people on the same dose can have very different results, because everybody’s different: biology, tolerance, dose, and what’s happening around the medication all matter. That last one is where people get stuck. The medication is the same everywhere. The plan around it isn’t.
GLP-1 Side Effects and Safety
GLP-1 medications can have gastrointestinal side effects. Managing those side effects is part of the care.
The most common are nausea, diarrhea, vomiting, constipation, and stomach pain. They usually show up as the dose increases and often ease over time. Adjusting the pace of your dose is one of the ways your physician helps.
All four medicines carry a boxed warning about thyroid C-cell tumors, which were seen in animal studies. They should not be used by anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Other serious risks include pancreatitis, gallbladder problems, kidney problems, and low blood sugar when combined with certain diabetes medicines. They are not for use during pregnancy.
This isn’t the complete list. Your physician walks through the full prescribing information and your own health history before anything is prescribed.
Which GLP-1 Is Best for Weight Loss? It Depends on You
There’s no best one. There’s the one that fits you, and the answer usually comes from a handful of questions:
- Do you have type 2 diabetes? That shapes which medicines are on the table and how they’re covered.
- What does your insurance cover, and for what? Coverage often follows the FDA-approved use.
- Other conditions, such as heart disease, sleep apnea, or fatty liver disease, where one option has a specific approval.
- How you’d take it. Transform prescribes weekly injections; your physician walks you through what that looks like.
- Your history, including pancreatitis, thyroid conditions, gallbladder issues, and digestive conditions.
- How you’ve responded to other medications in the past.
GLP-1 Pills, Wegovy HD, and Compounded Semaglutide
- Pills. The FDA has approved once-daily pills for weight management. Transform currently prescribes the weekly injections, which have the longest track record and the most research behind them.
- Higher doses. In March 2026, the FDA approved a higher 7.2 mg dose of Wegovy, called Wegovy HD, for certain adults.
- Compounded versions. Transform also prescribes compounded semaglutide and tirzepatide in some cases. Compounded medications are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness, or quality. When we prescribe one, it comes from a licensed compounding pharmacy and is managed by your physician the same way as any other medication.
GLP-1 Medication Costs and Insurance Coverage
Without insurance, list prices for these medications run roughly $1,000 a month or more. Both manufacturers now offer self-pay programs that bring Wegovy and Zepbound closer to $300 to $450 a month, and coverage, when you have it, usually follows the FDA-approved use: weight management plans may cover Wegovy or Zepbound, while Ozempic and Mounjaro are typically covered for type 2 diabetes.
Our team verifies your benefits before you start and walks you through cash-pay and financing options. Prices change often, so our cost and insurance guide has the current numbers.
Why the Medication Is Only Half the Plan
The prescription is the easy part. Research shows many people regain a significant amount of weight after stopping these medications, which means what happens around the medication decides whether the results last.
At Transform, your plan includes:
- Biometric testing first, so your plan is built on your biology, not a generic calorie count. Two people can weigh the same and have very different bodies, and we measure more than the scale: body composition, metabolic health, and how you feel.
- A physician who manages your dose. The goal: find the right dose for you, adjust it as your body changes, and help you through side effects and plateaus.
- Nutritional coaching and app tracking, so the habits that keep weight off are in place before you ever think about stopping.
- A long-term plan, including what maintenance looks like for you.
- Somewhere to go if medication isn’t enough. Our surgical weight loss options are right here, with the same team.
Let's Figure Out What Fits You
Bottom line: Wegovy and Zepbound are the on-label choices for weight management. Ozempic and Mounjaro belong in the conversation if you have type 2 diabetes. Whichever one fits, it works best with a physician managing it and a plan around it.
You don’t have to pick from four medicines on your own, and you shouldn’t have to. Your health, your biology, your goals: the right treatment takes all three into account. It starts with understanding you.
Frequently asked questions
Is Ozempic the same as Wegovy?
They contain the same active ingredient, semaglutide, but they are different products with different FDA approvals. Wegovy is approved for chronic weight management, and Ozempic is approved for type 2 diabetes. Using Ozempic for weight loss is off-label.
Is Zepbound the same as Mounjaro?
Both contain tirzepatide. Zepbound is FDA-approved for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro is approved for type 2 diabetes.
Which one works best for weight loss?
In a head-to-head trial, tirzepatide produced more weight loss on average than semaglutide. Individual results vary, and the best choice depends on your health history, coverage, and how you respond, which is what your physician helps you weigh.
Will my insurance cover it?
It depends on your plan. Coverage often follows the FDA-approved use, so medicines approved for type 2 diabetes are usually covered for diabetes, not weight loss. Our team runs an insurance verification check for you before you start.
What happens if I stop taking it?
Many people regain a significant amount of weight after stopping. That’s why your Transform plan includes coaching, tracking, and a long-term maintenance plan from the start.
Can I switch from one medication to another?
Sometimes, yes. Switching should be managed by a physician, who can decide on the right starting dose and timing for you.
How much do Wegovy and Zepbound cost without insurance?
List prices run roughly $1,000 a month or more, but manufacturer self-pay programs currently bring both closer to $300 to $450 a month. Prices change often, so check our cost guide for current numbers.
Can I get Ozempic for weight loss if I don't have diabetes?
Ozempic is FDA-approved for type 2 diabetes, so using it only for weight loss is off-label and rarely covered by insurance. For most people without diabetes, a physician will discuss Wegovy or Zepbound, which are approved for weight management.
